Albireo Announces Two New U.S. Patents Allowed for A4250 with Term into 2031
May 16, 2017 12:03 pm UTC| Business
BOSTON, May 16, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that the United States Patent and Trademark...
Albireo Announces Two New U.S. Patents Allowed for A4250 with Term into 2031
May 16, 2017 12:03 pm UTC| Business
BOSTON, May 16, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that the United States Patent and Trademark...
Albireo Announces Two New U.S. Patents Allowed for A4250 with Term into 2031
May 16, 2017 12:03 pm UTC| Business
BOSTON, May 16, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that the United States Patent and Trademark...
Reis, Inc. Declares Quarterly Cash Dividend of $0.17 Per Share
May 16, 2017 12:03 pm UTC| Business
NEW YORK, May 16, 2017 -- Reis, Inc.(NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today that on May 15, 2017, its Board of...
Reis, Inc. Declares Quarterly Cash Dividend of $0.17 Per Share
May 16, 2017 12:03 pm UTC| Business
NEW YORK, May 16, 2017 -- Reis, Inc.(NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today that on May 15, 2017, its Board of...
Reis, Inc. Declares Quarterly Cash Dividend of $0.17 Per Share
May 16, 2017 12:03 pm UTC| Business
NEW YORK, May 16, 2017 -- Reis, Inc.(NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today that on May 15, 2017, its Board of...
Reis, Inc. Declares Quarterly Cash Dividend of $0.17 Per Share
May 16, 2017 12:03 pm UTC| Business
NEW YORK, May 16, 2017 -- Reis, Inc.(NASDAQ:REIS) (“Reis” or the “Company”), a leading provider of commercial real estate market information and analytical tools, announced today that on May 15, 2017, its Board of...